{
    "xml": "<topic id=\"PHP954\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/atenolol\" basename=\"atenolol\" title=\"ATENOLOL\">\n<title>ATENOLOL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_441\" namespace=\"/interactions/list-of-drug-interactions/beta-blockers/atenolol\">Atenolol</xref>\n</p>\n<data name=\"vtmid\">87652004</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_613648210\" title=\"Beta-adrenoceptor blockers\">Beta-adrenoceptor blockers</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34515\" title=\"BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)\" namespace=\"/drug-classes/beta-adrenoceptor-blockers-systemic\">BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP70863\" outputclass=\"indicationsAndDose\" rev=\"1.20\" parent=\"/drugs/atenolol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypertension</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>25&#8211;50&#8239;mg daily, higher doses are rarely necessary.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Angina</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>100&#8239;mg daily in 1&#8211;2 divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Arrhythmias</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8211;100&#8239;mg daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8239;mg every 5&#8239;minutes (max. per dose 10&#8239;mg), repeated if necessary, given at a rate of 1&#8239;mg/minute.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>150&#8239;micrograms/kg every 12&#8239;hours if required, to be given over 20 minutes.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Migraine prophylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8211;200&#8239;mg daily in divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Early intervention within 12 hours of myocardial infarction</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8239;mg, to be given over 5 minutes, followed by (by mouth) 50&#8239;mg after 15&#8239;minutes, then (by mouth) 50&#8239;mg after 12&#8239;hours, then (by mouth) 100&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70769\" outputclass=\"unlicensedUse\" rev=\"1.9\" parent=\"/drugs/atenolol\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Use of atenolol for migraine prophylaxis is an unlicensed indication.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71000\" outputclass=\"breastFeeding\" parent=\"/drugs/atenolol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Water soluble beta-blockers such as atenolol are present in breast milk in greater amounts than other beta blockers.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70814\" outputclass=\"renalImpairment\" parent=\"/drugs/atenolol\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Max. 50&#8239;mg daily (10&#8239;mg on alternate days <i>intravenously</i>) if eGFR 15&#8211;35&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>; max. 25&#8239;mg daily or 50&#8239;mg on alternate days (10&#8239;mg every 4 days <i>intravenously</i>) if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71025\" outputclass=\"directionsForAdministration\" rev=\"1.6\" parent=\"/drugs/atenolol\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (<i>Tenormin</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5% or Sodium chloride 0.9%. Suggested infusion time 20 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP954-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/atenolol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74826\" title=\"Tablet\" namespace=\"/drugs/atenolol/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74840\" title=\"Oral solution\" namespace=\"/drugs/atenolol/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74833\" title=\"Solution for injection\" namespace=\"/drugs/atenolol/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85576\" namespace=\"/drugs/atenolol-with-nifedipine\" title=\"ATENOLOL WITH NIFEDIPINE\" count=\"1\" rel=\"backlink\">ATENOLOL WITH NIFEDIPINE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78218\" namespace=\"/treatment-summaries/beta-adrenoceptor-blocking-drugs\" title=\"Beta-adrenoceptor blocking drugs\" count=\"4\" rel=\"backlink\">Beta-adrenoceptor blocking drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78238\" namespace=\"/treatment-summaries/migraine\" title=\"Migraine\" count=\"1\" rel=\"backlink\">Migraine</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_441\" namespace=\"/interactions/list-of-drug-interactions/beta-blockers/atenolol\" title=\"Atenolol\" count=\"1\" rel=\"link\">Atenolol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34515\" namespace=\"/drug-classes/beta-adrenoceptor-blockers-systemic\" title=\"BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)\" count=\"1\" rel=\"link\">BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74826\" namespace=\"/drugs/atenolol/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74840\" namespace=\"/drugs/atenolol/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74833\" namespace=\"/drugs/atenolol/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP954",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/atenolol",
    "basename": "atenolol",
    "title": "ATENOLOL",
    "interactants": [
        {
            "id": "bnf_int_441",
            "label": "Atenolol"
        }
    ],
    "vtmid": "87652004",
    "drugClassification": [
        "Beta-adrenoceptor blockers"
    ],
    "inheritsFromClass": [
        "BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Hypertension",
                        "html": "Hypertension"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "25&#8211;50 mg daily, higher doses are rarely necessary.",
                        "html": "<p>25&#8211;50&#8239;mg daily, higher doses are rarely necessary.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Angina",
                        "html": "Angina"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "100 mg daily in 1&#8211;2 divided doses.",
                        "html": "<p>100&#8239;mg daily in 1&#8211;2 divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Arrhythmias",
                        "html": "Arrhythmias"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "50&#8211;100 mg daily.",
                        "html": "<p>50&#8211;100&#8239;mg daily.</p>"
                    },
                    {
                        "textContent": "2.5 mg every 5 minutes (max. per dose 10 mg), repeated if necessary, given at a rate of 1 mg/minute.",
                        "html": "<p>2.5&#8239;mg every 5&#8239;minutes (max. per dose 10&#8239;mg), repeated if necessary, given at a rate of 1&#8239;mg/minute.</p>"
                    },
                    {
                        "textContent": "150 micrograms/kg every 12 hours if required, to be given over 20 minutes.",
                        "html": "<p>150&#8239;micrograms/kg every 12&#8239;hours if required, to be given over 20 minutes.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Migraine prophylaxis",
                        "html": "Migraine prophylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "50&#8211;200 mg daily in divided doses.",
                        "html": "<p>50&#8211;200&#8239;mg daily in divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Early intervention within 12 hours of myocardial infarction",
                        "html": "Early intervention within 12 hours of myocardial infarction"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 5 mg, to be given over 5 minutes, followed by (by mouth) 50 mg after 15 minutes, then (by mouth) 50 mg after 12 hours, then (by mouth) 100 mg daily.",
                        "html": "<p>Initially 5&#8239;mg, to be given over 5 minutes, followed by (by mouth) 50&#8239;mg after 15&#8239;minutes, then (by mouth) 50&#8239;mg after 12&#8239;hours, then (by mouth) 100&#8239;mg daily.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Use of atenolol for migraine prophylaxis is an unlicensed indication.",
                "html": "<p>Use of atenolol for migraine prophylaxis is an unlicensed indication.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Water soluble beta-blockers such as atenolol are present in breast milk in greater amounts than other beta blockers.",
                "html": "<p>Water soluble beta-blockers such as atenolol are present in breast milk in greater amounts than other beta blockers.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Max. 50 mg daily (10 mg on alternate days intravenously) if eGFR 15&#8211;35 mL/minute/ 1.73 m2; max. 25 mg daily or 50 mg on alternate days (10 mg every 4 days intravenously) if eGFR less than 15 mL/minute/1.73 m2.",
                "html": "<p>Max. 50&#8239;mg daily (10&#8239;mg on alternate days <i>intravenously</i>) if eGFR 15&#8211;35&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>; max. 25&#8239;mg daily or 50&#8239;mg on alternate days (10&#8239;mg every 4 days <i>intravenously</i>) if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Tenormin ), give intermittently in Glucose 5% or Sodium chloride 0.9%. Suggested infusion time 20 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Tenormin</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5% or Sodium chloride 0.9%. Suggested infusion time 20 minutes.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74826",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74840",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74833",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85576",
                "label": "ATENOLOL WITH NIFEDIPINE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78218",
                "label": "Beta-adrenoceptor blocking drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78238",
                "label": "Migraine",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_441",
                "label": "Atenolol",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34515",
                "label": "BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74826",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74840",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74833",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}